Availability of Screening for Blood-Borne Viruses, Sexually Transmitted Infections, and HIV Pre-Exposure Prophylaxis (PrEP) at U.S. Substance Use Treatment Facilities Treating Stimulant Use Disorder.

Key Points

• This research examines the availability of screening for blood-borne viruses and PrEP in treatment facilities for stimulant use disorders.
• Survey of U.S. substance use treatment facilities
• Assessment of services provided related to HIV, HCV, STI testing and PrEP
• Evaluation of biospecimen collection practices
• Few facilities offered comprehensive testing for HIV, HCV, and STIs
• Many facilities collected biospecimens but did not provide related testing or treatment
• Highlighting the need for integrated prevention and management services